| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,250,000,000 |
| Market
Cap: |
93.98(B) |
| Last
Volume: |
13,677,776 |
Avg
Vol: |
11,996,025 |
| 52
Week Range: |
$40.25 - $66.16 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.8 |
| Insider 3/6 Months : 7.4 |
|
| Guru Rank Number : 97 |
| Guru Rank Value : 8.6 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. Co.'s primary products include: Revlimid®, in which Revlimid (lenalidomide) is an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma; and Eliquis®, in which Eliquis (apixaban) is an oral Factor Xa inhibitor indicated for the reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
2,000 |
13,571 |
13,571 |
| Total Buy Value |
$0 |
$99,560 |
$672,994 |
$672,994 |
| Total People Bought |
0 |
1 |
2 |
2 |
| Total Buy Transactions |
0 |
1 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
18,718 |
681,397 |
| Total Sell Value |
$0 |
$0 |
$1,146,397 |
$49,727,684 |
| Total People Sold |
0 |
0 |
2 |
6 |
| Total Sell Transactions |
0 |
0 |
2 |
12 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Leung Sandra |
EVP, General Counsel |
• – – |
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
68,896 |
488,677 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,540 |
441,948 |
|
- |
|
| Von Autenried Paul |
SVP, Enterp. Services & CIO |
• – – |
2018-03-10 |
4 |
D |
$67.92 |
$1,015,676 |
D/D |
(14,954) |
125,264 |
|
- |
|
| Von Autenried Paul |
SVP, Enterp. Services & CIO |
• – – |
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,275 |
136,441 |
|
- |
|
| Von Autenried Paul |
SVP, Enterp. Services & CIO |
• – – |
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,134 |
114,940 |
|
- |
|
| Judge Ann Powell |
SVP, Global Human Resources |
• – – |
2018-03-10 |
4 |
D |
$67.92 |
$1,228,197 |
D/D |
(18,083) |
62,749 |
|
- |
|
| Judge Ann Powell |
SVP, Global Human Resources |
• – – |
2018-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,044 |
75,370 |
|
- |
|
| Judge Ann Powell |
SVP, Global Human Resources |
• – – |
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,363 |
51,586 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2018-02-23 |
4 |
D |
$66.68 |
$1,387,144 |
D/D |
(20,803) |
281,545 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2018-02-23 |
4 |
OE |
$22.14 |
$829,364 |
D/D |
37,460 |
302,348 |
|
- |
|
| Samuels Theodore R. Ii |
Director |
– • – |
2017-12-15 |
4 |
B |
$62.30 |
$249,187 |
D/D |
4,000 |
22,000 |
2.39 |
- |
|
| Lynch Thomas J. Jr. |
EVP & Chief Scientific Officer |
• – – |
2017-12-12 |
4 |
S |
$63.24 |
$335,172 |
D/D |
(5,300) |
9,251 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2017-12-04 |
4 |
S |
$63.37 |
$9,922,601 |
D/D |
(156,582) |
427,791 |
|
- |
|
| Leung Sandra |
EVP, General Counsel |
• – – |
2017-12-04 |
4 |
OE |
$22.14 |
$3,466,725 |
D/D |
156,582 |
584,373 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2017-12-02 |
4 |
D |
$62.47 |
$180,039 |
D/D |
(2,882) |
264,888 |
|
- |
|
| Bancroft Charles A |
EVP & Chief Financial Officer |
• – – |
2017-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,401 |
267,770 |
|
- |
|
| Elicker John E |
SVP, Public Affairs & IR |
• – – |
2017-11-01 |
4 |
D |
$62.16 |
$13,862 |
D/D |
(223) |
67,943 |
|
- |
|
| Elicker John E |
SVP, Public Affairs & IR |
• – – |
2017-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
494 |
68,166 |
|
- |
|
| Caldarella Joseph C |
SVP & Controller |
• – – |
2017-09-06 |
4 |
S |
$60.00 |
$560,400 |
D/D |
(9,340) |
46,297 |
|
- |
|
| Nielsen Anne |
Chief Compliance & Ethics Off |
• – – |
2017-09-03 |
4 |
D |
$59.81 |
$50,061 |
D/D |
(837) |
37,974 |
|
- |
|
| Nielsen Anne |
Chief Compliance & Ethics Off |
• – – |
2017-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,594 |
38,811 |
|
- |
|
| Samuels Theodore R. Ii |
Director |
– • – |
2017-08-02 |
4 |
B |
$55.94 |
$335,622 |
D/D |
6,000 |
18,000 |
2.39 |
- |
|
| Gordon Murdo |
EVP, Chief Commercial Officer |
• – – |
2017-08-01 |
4 |
D |
$56.10 |
$43,926 |
D/D |
(783) |
27,968 |
|
- |
|
| Gordon Murdo |
EVP, Chief Commercial Officer |
• – – |
2017-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,510 |
28,751 |
|
- |
|
| Lynch Thomas J. Jr. |
EVP & Chief Scientific Officer |
• – – |
2017-05-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,551 |
14,551 |
|
- |
|
2225 Records found
|
|
Page 21 of 89 |
|
|
0.68 (1.65%) 
